Brief: Coya Therapeutics Inc Says On May 22, Chardan Capital Markets Agreed To End Restricted Period With Respect To Certain Shares Subject To Lock-Up Agreements
23/05/2023 22:48
May 23 (Reuters) - Coya Therapeutics Inc COYA.O :
* COYA THERAPEUTICS INC: ON MAY 22, CHARDAN CAPITAL MARKETS
AGREED
TO END RESTRICTED PERIOD WITH RESPECT TO CERTAIN SHARES SUBJECT
TO LOCK-UP AGREEMENTS
Further company coverage: COYA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coya Therapeutics
See all newsCoya Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Coya Therapeutics Q2 net loss widens as R&D costs rise
Coya Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Coya Therapeutics Entered Into Sales Agreement, May Offer And Sell From Time To Time Shares Of Co's Common Stock For Up To $30 Million
Brief: Coya Therapeutics Has Been Granted U.S. FDA Fast Track Designation For Coya 302 For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)